The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Treatments for gestational diabetes: a systematic review and meta-analysis
Open accessAbstract
Objective: To investigate the effectiveness of different treatments for gestational diabetes mellitus (GDM). Design: Systematic review, meta-analysis and network meta-analysis. Methods: Data sources were searched up to July 2016 and included MEDLINE and Embase. Randomised trials comparing treatments for GDM (packages of care (dietary and lifestyle interventions with pharmacological treatments as required), insulin, metformin, glibenclamide (glyburide)) were selected by two authors and double checked for accuracy. Outcomes included large for gestational age, shoulder dystocia, neonatal hypoglycaemia, caesarean section and pre-eclampsia. We pooled data using random-effects meta-analyses and used Bayesian network meta-analysis to compare pharmacological treatments (ie, including treatments not directly compared within a trial). Results: Forty-two trials were included, the reporting of which was generally poor with unclear or high risk of bias. Packages of care varied in their composition and reduced the risk of most adverse perinatal outcomes compared with routine care (eg, large for gestational age: relative risk0.58 (95% CI 0.49 to 0.68; I 2 =0%; trials 8; participants 3462). Network meta-analyses suggest that metformin had the highest probability of being the most effective treatment in reducing the risk of most outcomes compared with insulin or glibenclamide. Conclusions: Evidence shows that packages of care are effective in reducing the risk of most adverse perinatal outcomes. However, trials often include few women, are poorly reported with unclear or high risk of bias and report few outcomes. The contribution of each treatment within the packages of care remains unclear. Large well-designed and well-conducted trials are urgently needed. Trial registration number: PROSPERO CRD42013004608.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DM during pregnancy and even maternal obesity itself1418 set the stage for a vicious cycle with offspring of mothers with DM during pregnancy being more likely to become obese and to develop DM at younger ages.1420”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1420]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The HAPO study confirmed findings in Pima Indians1409 that, even among offspring of women without GDM as it is currently defined, there is a linear association between maternal glucose concentration during pregnancy and newborn weight, rates of large-for-gestational-age, and cesarean delivery.64,1418–1421”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1420]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment of higherthreshold maternal hyperglycemia, as identified by the two-step approach, reduces rates of neonatal macrosomia, large-forgestational-age births (207), and shoulder dystocia without increasing small-forgestational-age births.”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [207]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A package of care (a combination of treatments starting with dietary modifications and/or exercise and/or pharmacological treatments) is effective in reducing the risk of most adverse perinatal outcomes of GDM, but the evidence is of low quality245.”
From A global view of hypertensive disorders and diabetes mellitus during pregnancy (2022) · cites this paper as [245]
In the citing paper
“A meta-analysis found poorly reported results and potential bias from randomized trials comparing treatments for GDM [11].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Combination of direct and indirect evidence in mixed treatment comparisons
Lu, G., & Ades, A. E. (2004) · Statistics in Medicine · doi:10.1002/sim.1875 · Cited by 2,166
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Research works printed but not linked: 4
- Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking a systematic review York: CRD, University of York, 2009.
- Zinnat, 2013, Can metformin be used in place of insulin for the treatment of GDM for low resource countries?, BJOG, 120, 35
- 10.1111/j.1471-0528.2010.02763.x · DOI · Paper page
- O’Sullivan, 1967, Diabetes, 13, 278
Cited by
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002960 · Cited by 470
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Wilson, R. D., Caughey, A. B., Wood, S. L., Macones, G. A., Wrench, I. J., Huang, J., Norman, M., Pettersson, K., Fawcett, W. J., Shalabi, M. M., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.09.015 · Cited by 315
A global view of hypertensive disorders and diabetes mellitus during pregnancy
Jiang, L., Tang, K., Magee, L. A., von Dadelszen, P., Ekeroma, A., Li, X., Zhang, E., & Bhutta, Z. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00734-y · Cited by 314
Role of Oxidative Stress and Inflammation in Gestational Diabetes Mellitus
Saucedo, R., Ortega-Camarillo, C., Ferreira-Hermosillo, A., Díaz-Velázquez, M. F., Meixueiro-Calderón, C., & Valencia-Ortega, J. (2023) · Antioxidants · doi:10.3390/antiox12101812 · Cited by 179
“On the other hand, treatment failure with metformin is 33.8%, and treatment failure with glyburide is 20%; therefore, women require the addition of insulin to maintain adequate glycemic control [67,68].”
InfluentialTreatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
Martis, R., Crowther, C. A., Shepherd, E., Alsweiler, J., Downie, M. R., & Brown, J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012327.pub2 · Cited by 159
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
Barbour, L. A., Scifres, C., Valent, A. M., Friedman, J. E., Buchanan, T. A., Coustan, D., Aagaard, K., Thornburg, K. L., Catalano, P. M., Galan, H. L., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.013 · Cited by 101
Tsakiridis, I. G., Giouleka, S., Mamopoulos, A. M., Kourtis, A., Athanasiadis, A. P., Filopoulou, D., & Dagklis, T. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000899 · Cited by 104
SMFM statement: pharmacological treatment of gestational diabetes
(2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.01.041 · Cited by 94
“metformin or insulin if glucose levels are not adequately controlled with dietary and 111 lifestyle modifications (8).”
BackgroundZheng, T., Ye, W., Wang, X., Li, X., Zhang, J., Little, J., Zhou, L., & Zhang, L. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2374-8 · Cited by 87
Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
Martis, R., Brown, J., Alsweiler, J. M., Downie, M. R., & Crowther, C. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012327 · Cited by 87
Metformin in the management of diabetes during pregnancy and lactation
Priya, G., & Kalra, S. (2018) · Drugs in Context · doi:10.7573/dic.212523 · Cited by 99
“Moreover, Butalia and colleagues [57] and Farrar and colleagues [56] did not demonstrate any increase in rates of preterm deliveries with metformin in recent metaanalyses.”
BackgroundShpakov, A. O. (2021) · Pharmaceuticals · doi:10.3390/ph14010042 · Cited by 91
Wexler, D. J., Powe, C. E., Barbour, L. A., Buchanan, T., Coustan, D. R., Corcoy, R., Damm, P., Dunne, F., Feig, D. S., Ferrara, A., et al. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002726 · Cited by 80
Feig, D. S., Sanchez, J. J., Murphy, K. E., Asztalos, E., Zinman, B., Simmons, D., Haqq, A. M., Fantus, I. G., Lipscombe, L., Armson, A., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00004-9 · Cited by 61
McBride, N., White, S. L., Lucilla, P., Farrar, D., West, J., Sattar, N. A., Nelson, S. M., Wright, J., Mason, D., Suderman, M. J., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01819-z · Cited by 52
“These pregnancy-related disorders often co-occur, with women with GDM more likely to have pregnancies complicated by hypertension or pre-eclampsia (PE), and their offspring being born LGA [2].”
BackgroundSelf-citationGestational diabetes mellitus: Multi-disciplinary treatment approaches
Kintiraki, E., & Goulis, D. G. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.025 · Cited by 56
Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function
Jorquera, G., Echiburú, B., Crisosto, N., Sotomayor‐Zárate, R., Maliqueo, M. A., & Cruz, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00653 · Cited by 49
“GDM is associated with short- and long-term sequelae on both, mother and offspring (Dall et al., 2014; Farrar et al., 2017).”
BackgroundBehboudi‐Gandevani, S., Yarandi, R. B., Panahi, M. H., & Vaismoradi, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.640004 · Cited by 52
Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach
Barbour, L. A., & Feig, D. S. (2019) · Diabetes Care · doi:10.2337/dci18-0055 · Cited by 44
Benton, M., Silverio, S. A., & Ismail, K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288395 · Cited by 43
“Management of GDM is demanding on women and involves self-monitoring of blood glucose, diet and exercise modification, and in some cases the use of pharmacological treatment including metformin and insulin [7].”
BackgroundThe Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus
Zakaria, H., Abusnana, S., Mussa, B. M., Dhaheri, A. S. A., Stojanovska, L., Mohamad, M. N., Saleh, S. T., Ali, H. I., & Ismail, L. C. (2023) · Medicina · doi:10.3390/medicina59020287 · Cited by 43
Xu, Y. X. Z., Xi, S., & Qian, X. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9182595 · Cited by 42
“A meta-analysis found poorly reported results and potential bias from randomized trials comparing treatments for GDM [11].”
MethodPfeiffer, S., Sánchez-Lechuga, B., Donovan, P., Halang, L., Prehn, J. H. M., Campos‐Caro, A., Byrne, M. M., & López‐Tinoco, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-57838-6 · Cited by 40
Wang, X., Liu, W., Chen, H., & Chen, Q. (2021) · Gynecologic and Obstetric Investigation · doi:10.1159/000515893 · Cited by 37
Simmons, D., Immanuel, J., Hague, W. M., Teede, H., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M., Wong, V., Hibbert, E. J., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1667 · Cited by 36
Management of pregestational diabetes mellitus: a comparison of guidelines
Tsakiridis, I. G., Mamopoulos, A. M., Athanasiadis, A. P., Kourtis, A., & Dagklis, T. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1719481 · Cited by 36
“In addition, a recent network meta-analysis found that metformin had the highest probability to reduce possible complications, when compared with glyburide and insulin [81].”
BackgroundPaavilainen, E., Tertti, K., Nikkinen, H., Veijola, R., Vääräsmäki, M., Loo, B.-M., Tossavainen, P. H., Rönnemaa, T., & Niinikoski, H. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14589 · Cited by 37
“Adequate treatment of GDM reduces maternal and foetal adverse effects.(6) First-line treatment includes combined nutritional therapy and exercise, and pharmacological treatment is added if optimal glucose levels are not obtained through lifestyle interventions.”
BackgroundBogdanet, D., Reddin, C., Macken, E., Griffin, T. P., Fhelelboom, N., Biesty, L., Thangaratinam, S., Dempsey, E. M., Crowther, C. A., Galjaard, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4935-9 · Cited by 33
Fatty liver in pregnancy: a narrative review of two distinct conditions
Azzaroli, F., Mazzella, G., Marchesini, G., Brodosi, L., & Petroni, M. L. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1715210 · Cited by 32
Oral Agents for the Treatment of Gestational Diabetes
Finneran, M. M., & Landon, M. B. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1093-2 · Cited by 34
Gianfrancesco, C., Darwin, Z. J., Albar, S., Alwan, N. A., Carter, M., Haddrill, R., McGowan, L., Morris, M. A., Scott, E., Smith, D. M., et al. (2018) · Nutrients · doi:10.3390/nu10091147 · Cited by 29
“The main treatment aim is to maintain healthy blood glucose levels throughout pregnancy to reduce the risks of complications for the mother and child; for example: macrosomia, stillbirth, and birth-related trauma [2].”
BackgroundInappropriate gestational weight gain impact on maternofetal outcomes in gestational diabetes
Monteiro, S. S., Santos, T., Fonseca, L., Saraiva, M., Pichel, F., Pinto, C., Pereira, M. T., Vilaverde, J., Almeida, M. C., & Dores, J. M. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2159063 · Cited by 28
Glucose Lowering Treatment Modalities of Type 2 Diabetes Mellitus
Canpolat, A. G., & Şahin, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_516 · Cited by 29
Venkatesh, K. K., Chiang, C., Castillo, W. C., Battarbee, A., Donneyong, M. M., Harper, L. M., Costantine, M. M., Saade, G. A., Werner, E., Boggess, K., et al. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16960 · Cited by 29
García‐Patterson, A., Balsells, M., Solà, I., Gich, I. J., & Corcoy, R. (2022) · Diabetic Medicine · doi:10.1111/dme.14998 · Cited by 27
The Role of Lifestyle Intervention in the Prevention and Treatment of Gestational Diabetes
Moholdt, T. T., Hayman, M., Shorakae, S., Brown, W. J., & Harrison, C. L. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1722208 · Cited by 29
Feig, D. S. (2022) · Diabetes Care · doi:10.2337/dci21-0027 · Cited by 25
Pharmacological treatment of gestational diabetes mellitus: point/counterpoint
Langer, O. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.01.024 · Cited by 27
Wilson, R. D., Monks, D. T., Sharawi, N., Bamber, J., Panelli, D. M., Sauro, K. M., Shah, P. S., Muraca, G. M., Metcalfe, A., Wood, S. L., et al. (2026) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.01.014 · Cited by 22
Oliveira, M. M. D., Andrade, K. F. D. O., Lima, G. H. S., & Rocha, T. C. (2022) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2022rw6155 · Cited by 21
“strategies in insulin therapy for control and treatment of GDM.(2,17,21) There is still little knowledge regarding”
MethodInfluentialBerry, D. C., Thomas, S., Dorman, K. F., Ivins, A., Abreu, M. D. L. Á., Young, L., & Boggess, K. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2108-3 · Cited by 21
A mouse model of gestation-specific transient hyperglycemia for translational studies
Li, H. Y., Liu, Y. X., Harvey, L., Shafaeizadeh, S., van der Beek, E. M., & Han, W. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0516 · Cited by 24
Cooray, S. D., Boyle, J. A., Soldatos, G., Wijeyaratne, L. A., & Teede, H. J. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1151-0 · Cited by 21
Betatrophin for diagnosis and prognosis of mothers with gestational diabetes mellitus
Pan, R., Zhang, H., Yu, S., Deng, J., Ma, S., Li, Y., Yuan, G., & Wang, J. (2018) · Journal of International Medical Research · doi:10.1177/0300060518808683 · Cited by 20
“Betatrophin was assessed to examine the diagnostic characteristics of GDM. Results: The betatrophin concentration was remarkably higher in patients with than without GDM.”
BackgroundInfluentialPharmacologic Treatment of Diabetes in Pregnancy
Bishop, K. C., Harris, B. S., Boyd, B. K., Reiff, E. S., Brown, L., & Kuller, J. A. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000671 · Cited by 21
“A more recent meta-analysis found no differences between metformin and insulin in outcomes for LGA, macrosomia, neonatal hypoglycemia, or cesarean delivery rate.(50)”
MethodHyperglycaemia in pregnancy: the role of ethnicity and geography in risk and outcomes
Yuen, L., Hannah, W., Hare, M. J. L., & Simmons, D. S. (2025) · Diabetologia · doi:10.1007/s00125-025-06510-7 · Cited by 21
“Treatment for GDM is beneficial from this time [64].”
Nikparast, A., Rahmani, J., Bagheri, R., Mohammadpour, S., Shadnoosh, M., Wong, A., & Ghanavati, M. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14022 · Cited by 21
Metformin in gestational diabetes: physiological actions and clinical applications
Mason, T., Alesi, S., Fernando, M., Vanky, E., Teede, H. J., & Mousa, A. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01049-w · Cited by 20
“Most of these (with many overlapping studies) report that metformin is equally 135–141 , if not more 142–144 , efficacious and safe in comparison to insulin and other oral hypoglycaemic agents.”
Musa, O. A. H., Syed, A., Mohamed, A. M., Chivese, T., Clark, J. M., Furuya‐Kanamori, L., Xu, C., Toft, E. S., Bashir, M., Abou‐Samra, A., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105546 · Cited by 27
Huhtala, M. S., Rönnemaa, T., Pellonperä, O., & Tertti, K. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002022 · Cited by 17
Tehrani, F. R., Rahmati, M., Farzadfar, F., Abedini, M., Farahmand, M., Hosseinpanah, F., Hadaegh, F., Torkestani, F., Valizadeh, M., Azizi, F., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1039643 · Cited by 19
Bodier, L., Lous, M. L., Isly, H., Derrien, C., & Vaduva, P. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101622 · Cited by 21
LeMay‐Nedjelski, L., Yonemitsu, C., Asbury, M. R., Butcher, J., Ley, S. H., Hanley, A. J., Kiss, A., Unger, S. L., Copeland, J. K., Wang, P. W., et al. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab270 · Cited by 17
She, W., Li, T., Liu, Y., & Liu, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s334728 · Cited by 17
Novel therapies for diabetes mellitus in pregnancy
Feghali, M. N., & Scifres, C. (2018) · BMJ · doi:10.1136/bmj.k2034 · Cited by 17
Kouhkan, A., Baradaran, H. R., Hosseini, R., Arabipoor, A., Moini, A., Pirjani, R., Khajavi, A., & Khamseh, M. E. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0525-4 · Cited by 16
Research progress of metformin in gestational diabetes mellitus: a narrative review
Ouyang, H., Al-Mureish, A., & Wu, N. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-192 · Cited by 19
“Such adverse effects decrease over time and may be mitigated by reducing the dose and taking metformin with food (79-80).”
BackgroundBenton, M., Hotung, N., Bird, J., Ismail, K., & Silverio, S. A. (2025) · Journal of Health Psychology · doi:10.1177/13591053241241863 · Cited by 15
“Consequently, GDM pregnancies become highly medicalised (Diane et al., 2017).”
Focus on Metformin: Its Role and Safety in Pregnancy and Beyond
Newman, C., Rabbitt, L., Ero, A., & Dunne, F. (2023) · Drugs · doi:10.1007/s40265-023-01899-0 · Cited by 14
“[113], 2017 Pharmacological and lifestyle 42 RCT Metformin vs.”
BackgroundApps and the Woman With Gestational Diabetes Mellitus
Immanuel, J., & Simmons, D. S. (2021) · Diabetes Care · doi:10.2337/dci20-0068 · Cited by 14
Ouyang, H., & Wu, N. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01142-7 · Cited by 16
Yu, Y., Platt, R. W., Reynier, P., Yu, O. H. Y., & Filion, K. B. (2023) · Diabetic Medicine · doi:10.1111/dme.15108 · Cited by 14
Yarandi, R. B., Amiri, M., Tehrani, F. R., & Behboudi‐Gandevani, S. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13603 · Cited by 17
Mu, A., Chen, Y., Lv, Y., & Wang, W. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/4882061 · Cited by 14
“Diet therapy, exercise therapy, and insulin therapy are all available choice for the treatment of GDM in the clinical setting [25].”
BackgroundRoto, S., Nupponen, I. K., Kalliala, I. E. J., & Kaijomaa, M. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06596-8 · Cited by 14
“Fetal macrosomia is known to increase the risk of shoulder dystocia more than tenfold [35] and in these situations, a planned delivery at early term has been demonstrated to reduce the risk of shoulder dystocia [34].”
BackgroundTehrani, F. R., Behboudi‐Gandevani, S., Abedini, M., Soleymani-Dodaran, M., Khalili, D., Farzadfar, F., Hosseinpanah, F., Hadaegh, F., Valizadeh, M., Torkestani, F., et al. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0493-z · Cited by 13
Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice
Faradonbeh, F. A., Igreja, I. C., Laštůvková, H., Cermanová, J., Hroch, M., Faistova, H., Mokrý, J., Nová, Z., Uher, M., Nachtigal, P., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109525 · Cited by 14
Edwards, K. J., Maslin, K., Andrade, J., Jones, R. B., & Shawe, J. (2022) · JBI Evidence Synthesis · doi:10.11124/jbies-21-00294 · Cited by 13
Drugs to Control Diabetes During Pregnancy
Feghali, M. N., Umans, J. G., & Catalano, P. M. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.005 · Cited by 16
Rodrigo, N., Randall, D., Al-Hial, F. A., Pak, K. L. M., Kim, A. J., & Glastras, S. J. (2023) · Nutrients · doi:10.3390/nu15051226 · Cited by 12
“Treatment benefit has been further supported by many other studies [21,22].”
ResultHuhtala, M. S., Nikkinen, H., Paavilainen, E., Niinikoski, H., Vääräsmäki, M., Loo, B.-M., Rönnemaa, T., & Tertti, K. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14343 · Cited by 12
A Review on the Use of Metformin in Pregnancy and Its Associated Fetal Outcomes
Verma, V., & Mehendale, A. M. (2022) · Cureus · doi:10.7759/cureus.30039 · Cited by 12
“Compared to insulin and Glibenclamide therapies, macrosomia, or large for gestational age births, newborn hypoglycemia, and admission of the infant to neonatal intensive care units [13] are all at a decreased risk when metformin medication is used to treat gestational diabetes mellitus [25,26].”
BackgroundLi, W., Kim, C., Howell, E. A., Janevic, T. M., Liu, B., Shi, L., & Li, Y. (2022) · Value in Health · doi:10.1016/j.jval.2022.07.014 · Cited by 11
Brzozowska, M. M., Puvanendran, A., Bliuc, D., Zuschmann, A., Piotrowicz, A. K., & O’Sullivan, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1119134 · Cited by 11
Absalom, G., Zinga, J., Margerison, C., & van der Pligt, P. (2019) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12682 · Cited by 13
McLennan, N.-M., Hazlehurst, J., Thangaratinam, S., & Reynolds, R. M. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1046 · Cited by 10
The impact of gestational diabetes mellitus on perceived mother-infant bonding: a qualitative study
Benton, M., Bird, J. C., Pawlby, S. J., & Ismail, K. (2023) · Journal of Reproductive and Infant Psychology · doi:10.1080/02646838.2023.2239834 · Cited by 10
“…in the pursuit of optimal blood glucose levels, such as self-monitoring blood glucose, diet and exercise modification, highly frequent monitoring by healthcare professionals, and for some women, administering pharmacological treatment including metformin and insulin (Farrar et al., 2017).”
Recent advances in the antepartum management of diabetes
Mitric, C., Desilets, J., & Brown, R. N. (2019) · F1000Research · doi:10.12688/f1000research.15795.1 · Cited by 11
The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy
Blair, R. A., Rosenberg, E. A., & Palermo, N. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1243-1 · Cited by 10
Gestational Diabetes and Type 2 Diabetes During Pregnancy
Mukerji, G., Bacon, S., & Feig, D. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00022-2 · Cited by 13
Advanced AI-Driven Prediction of Pregnancy-Related Adverse Drug Reactions
Peng, J., Fu, L., Yang, G., & Cao, D. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01657 · Cited by 9
Lofthouse, E. M., Cleal, J. K., Hudson, G., Lewis, R. M., & Sengers, B. G. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105436 · Cited by 9
“Maternal treatment for this condition consists of dietary modifications and if this proves insufficient, medication with insulin or drugs is required [11, 13].”
BackgroundMarkussen, L. T., Kivelä, J., Lindström, J., Ashrafi, R. A., Heinonen, S. T., Koivusalo, S. B., & Meinilä, J. M. (2023) · BMC Nutrition · doi:10.1186/s40795-023-00744-7 · Cited by 10
“Currently, the preferred first-line treatment for GDM is dietary intervention for glycemic control [10, 11].”
BackgroundTreatment of Gestational Diabetes Mellitus and Offspring Early Childhood Growth
Feghali, M. N., Atlass, J., Abebe, K. Z., COMER, D. M., Catov, J. M., Caritis, S. N., Arslanian, S. A., & Scifres, C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa742 · Cited by 9
Li, F., Liu, L., Hu, Y., Marx, C. M., & Liu, W. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-022-01438-z · Cited by 11
GESTATIONAL DIABETES MELLITUS: Challenges in diagnostics, management and impact
de Wit, L. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/195 · Cited by 9
Wang, X., Zheng, M., Qin, S., Li, Y., & Xu, H. (2025) · Ginekologia Polska · doi:10.5603/gpl.102215 · Cited by 8
Venkatesh, K. K., MacPherson, C., Clifton, R. G., Powe, C. E., Bartholomew, A. B. C., Gregory, D., Trinh, A., McAlearney, A. S., Fiechtner, L. G., Catalano, P. M., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-091176 · Cited by 9
“Using data from recent meta-analyses that compared the two treatment regimens, 18 19 71 and the most recent RCT (although comparing glyburide to insulin) that assessed the same primary composite outcome as in our study, 23 we estimate the frequency of the primary composite peri-natal outcome to be…”
Metformin administration during pregnancy — current insight
Skibińska, M., Żurawska-Kliś, M., Krekora, M., & Cypryk, K. (2021) · Ginekologia Polska · doi:10.5603/gp.a2020.0149 · Cited by 8
“[17] meta-analysis, two groups were analysed: the first one included patients treated with metformin and insulin added when necessary, while the other one was comprised of women treated only with insulin.”
MethodPayne, E., Palmer, G., Rollo, M. E., Ryan, K. E., Harrison, S., Collins, C. E., Wynne, K., Brown, L., & Schumacher, T. L. (2022) · Nutrition & Dietetics · doi:10.1111/1747-0080.12722 · Cited by 8
“48,49 One review article investigated pregnancy outcomes of women and infants in metropolitan and rural areas; however, the type of review was not specified and was limited to pre-pregnancy diabetes in the Australian context.”
Metformin for Diabetes in Pregnancy: Are We Closer to Defining Its Role?
Feig, D. S. (2023) · JAMA · doi:10.1001/jama.2023.18589 · Cited by 8
Brinkmann, M. L. S., Krasilnikoff, N. J., Chaaban, M. A., Luef, B. M., Newman, C., Dunne, F., Jensen, D. M., & Vinter, C. A. (2025) · Diabetic Medicine · doi:10.1111/dme.70173 · Cited by 7
“Farrar et al., 15 another systematic review and meta-analysis incorporating newer trials previously excluded from earlier reviews, reaffirmed metformin's benefits across a spectrum of pregnancy outcomes, solidifying its acceptance in clinical practice.”
InfluentialPrüst, J. T., Brummaier, T., Wah, M., Yee, H. H., Win, N. N., Pimanpanarak, M., Min, A. M., Gilder, M. E., Tun, N. W., Ilozumba, O., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17743.1 · Cited by 8
Hribar, K., Eichhorn, D., Bongiovanni, L., Koster, M. H., Kloosterhuis, N., de Bruin, A., Oosterveer, M. H., Kruit, J. K., & van der Beek, E. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-65239-2 · Cited by 7
“Although dietary recommendations are provided to women with GDM in standard care 53 and have been shown to be effective 54–56 , lifestyle intervention programs may not work to reduce long-term risks such as MASLD in lean insulin secretion-driven GDM.”
BackgroundHarnois‐Leblanc, S., & Hivert, M. (2024) · Diabetes · doi:10.2337/dbi24-0014 · Cited by 7
Metadata
- Authors
- Farrar, D., Simmonds, M., Bryant, M., Sheldon, T. A., Tuffnell, D., Golder, S., & Lawlor, D. A.
- Affiliations
- Bradford Royal Infirmary (GB)
- University of York (GB)
- University of Leeds (GB)
- Bradford Teaching Hospitals NHS Foundation Trust (GB)
- University of Bristol (GB)
- Corresponding author
- Farrar, Diane
- ORCID
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-06
- Volume
- 7
- Issue
- 6
- Pages
- e015557
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC5734427
- OpenAlex
- W2626502458
- Cited by
- 163
- References
- 83
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 17 · 2023: 22 · 2022: 22 · 2021: 26 · 2020: 17 · 2019: 16 · 2018: 16 · 2017: 2
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMJ Open (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion, cc-by)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion, public-domain)
- HighWire Press Open Archive (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Funders
- Health Technology Assessment Programme
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, treatment effectiveness, insulin therapy, metformin, glibenclamide, dietary and lifestyle interventions, perinatal outcomes, large for gestational age, shoulder dystocia, neonatal hypoglycemia, cesarean section, preeclampsia
- MeSH terms
- Bayes Theorem, Cesarean Section, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Randomized Controlled Trials as Topic, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.